Attitudes of patients, caregivers and health care professionals towards deprescribing in older adults with life-limiting illness and limited life expectancy

*This study is now closed* 

The older population in Australia is rising and so is life-limiting illnesses such as cancer and dementia, and consequently the use of medication.

However, evidence suggest that this vulnerable group of patients continue to receive medications that are considered inappropriate. Therefore, a potential approach to minimise the risks associated with medications and consequently improve their quality of life is 'deprescribing'.

Deprescribing is a process that involves withdrawal (or dose reduction) of an inappropriate medication, supervised by a healthcare professional. However, its implementation in clinical practice is challenging. Hence, understanding the attitudes and beliefs of patients, patient parties and health care professionals, who are part of the process, could assist in developing effective deprescribing strategies.

Therefore, this survey aims to understand your attitude and beliefs towards deprescribing in older patients with life-limiting illness and limited life expectancy.

This research study runs from 01/06/2020 to 31/11/2020.

Participation benefits:

Contribute to the exploration of deprescribing research in Australia.

Eligibility:

Register your interest:

*This study is now closed*

Access the survey on your mobile, PC, tablet.

For more details, please email Shakti Shrestha (PhD candidate) or phone +61 402 981 389.

This study has been approved by The University of Queensland Human Research Ethics Committee [Approval No. 2019002110]